Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm® 10/2018
vorherige Ausgabe nächste Ausgabe

SPOT ON
Atrial fibrillation: new oral anticoagulants in the „real world“ (short version)
What is the matter with the Cochrane board?

THERAPY FROM A CRITICAL VIEWPOINT
New European hypertension guideline: classification, treatment initiation, target values

a-t READERS QUESTIONS AND COMMENTS
Pneumonia with proton pump inhibitors?

IN BRIEF
Nitrosamine contaminated sartanes – batches of losartan and irbesartan also affected
Primary prevention with acetylsalicylic acid – new findings?
KIJIMEA REIZDARM against irritable bowel syndrome?

SIDE EFFECTS
Increased skin cancer risk with hydrochlorothiazide – what are the consequences?
Further restrictions of use of gyrase inhibitors
Increased risk of PARKINSONs disease with methylphenidate (RITALIN, Generics)

CURRENT ADR NETWORK REPORT
Intrauterine devices: caution – risk of breakage  free article 

e a-t ON THE INTERNET
Atrial fibrillation: new oral anticoagulants in the „real world“ (long version)
© 2018 arznei-telegramm